These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33427194)

  • 1. Who Will Pay for the COVID-19 Vaccines for Africa?
    Lucero-Prisno DE; Ogunkola IO; Imo UF; Adebisi YA
    Am J Trop Med Hyg; 2021 Jan; 104(3):794-796. PubMed ID: 33427194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed Access to COVID-19 Vaccines: A Perspective on Low-income Countries in Africa.
    Hassan MA; Aliyu S
    Int J Health Serv; 2022 Jul; 52(3):323-329. PubMed ID: 35469499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 vaccine access in Africa: Global distribution, vaccine platforms, and challenges ahead.
    Massinga Loembé M; Nkengasong JN
    Immunity; 2021 Jul; 54(7):1353-1362. PubMed ID: 34260880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis.
    So AD; Woo J
    BMJ; 2020 Dec; 371():m4750. PubMed ID: 33323376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cash payments in Africa could boost vaccine uptake.
    Arezki R
    Nature; 2021 Aug; 596(7870):9. PubMed ID: 34345045
    [No Abstract]   [Full Text] [Related]  

  • 6. Equitable and Feasible Distribution of SARS-CoV-2 Vaccines for All in Africa.
    Rogers AB; Barrie MB; Fallah MP; Kelly JD
    Am J Trop Med Hyg; 2021 Jun; 105(2):278-280. PubMed ID: 34181573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Equal access of COVID-19 vaccine distribution in Africa: Challenges and way forward.
    Aborode AT; Olofinsao OA; Osmond E; Batubo AP; Fayemiro O; Sherifdeen O; Muraina L; Obadawo BS; Ahmad S; Fajemisin EA
    J Med Virol; 2021 Sep; 93(9):5212-5215. PubMed ID: 34009657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 vaccines and vaccination: how prepared is Africa?
    Ariyo OE; Oladipo EK; Osasona OG; Obe O; Olomojobi F
    Pan Afr Med J; 2021; 39():107. PubMed ID: 34512843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 vaccines for children and adolescents in Africa: aligning our priorities to situational realities.
    Govender K; Nyamaruze P; McKerrow N; Meyer-Weitz A; Cowden RG
    BMJ Glob Health; 2022 Feb; 7(2):. PubMed ID: 35153193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 vaccine equity in Africa.
    Turyasingura N; James WG; Vermund SH
    Trans R Soc Trop Med Hyg; 2023 Jun; 117(6):470-472. PubMed ID: 36622662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The COVID-19 experience in Africa and the Middle East.
    Bizri AR; Al Akoury N; Mhlanga T; Morales GDC; Haridy H; Hussey GD; Srivastava A
    Ann Med; 2023 Dec; 55(1):2222641. PubMed ID: 37345635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 vaccines: Global challenges and prospects forum recommendations.
    Boudjelal M; Almajed F; Salman AM; Alharbi NK; Colangelo M; Michelotti JM; Olinger G; Baker M; Hill AVS; Alaskar A
    Int J Infect Dis; 2021 Apr; 105():448-451. PubMed ID: 33652065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dealing with vaccine hesitancy in Africa: the prospective COVID-19 vaccine context.
    Afolabi AA; Ilesanmi OS
    Pan Afr Med J; 2021; 38():3. PubMed ID: 33520072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of prospective pathways and impacts of COVID-19 on the accessibility, safety, quality, and affordability of essential medicines and vaccines for universal health coverage in Africa.
    Amimo F; Lambert B; Magit A; Hashizume M
    Global Health; 2021 Apr; 17(1):42. PubMed ID: 33832487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Access to COVID-19 vaccines and testing in Africa: the importance of COVAX - Nigeria as a case study.
    Grenfell RFQ; Oyeyemi OT
    Pathog Glob Health; 2023 Mar; 117(2):152-166. PubMed ID: 35770309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urgent support mechanism: saving millions of COVID-19 vaccines from expiry in Africa.
    Fallah MP; Sembuche S; Kabwe PC; Dereje N; Abubakar T; Chipendo T; Ojo J; Bamutura M; Shaweno T; Ramakhunoane S; Ts'oeu S; Ndoula ST; Agoambin N; Kangbai DM; Jalloh MB; Tinuga F; Mutayoba R; Jalang'o RE; Kiarie J; Legge GA; David V; Clarke AT; Kamara PS; Kalangwa K; Sakanga V; Ndembi N; Raji T; Abdulaziz M
    BMJ Glob Health; 2024 Jun; 9(6):. PubMed ID: 38844381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Priority setting during the COVID-19 pandemic: going beyond vaccines.
    Williams I; Essue B; Nouvet E; Sandman L; Razavi SD; Noorulhuda M; Goold S; Danis M; Biemba G; Abelson J; Kapiriri L
    BMJ Glob Health; 2021 Jan; 6(1):. PubMed ID: 33461979
    [No Abstract]   [Full Text] [Related]  

  • 18. Hard choices: Ethical challenges in phase 1 of COVID-19 vaccine roll-out in South Africa.
    Moodley K; Blockman M; Pienaar D; Hawkridge AJ; Meintjes J; Davies MA; London L
    S Afr Med J; 2021 Mar; 111(6):554-558. PubMed ID: 34382565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incentivising wealthy nations to participate in the COVID-19 Vaccine Global Access Facility (COVAX): a game theory perspective.
    McAdams D; McDade KK; Ogbuoji O; Johnson M; Dixit S; Yamey G
    BMJ Glob Health; 2020 Nov; 5(11):. PubMed ID: 33257418
    [No Abstract]   [Full Text] [Related]  

  • 20. Adverse Events to SARS-CoV-2 (COVID-19) Vaccines and Policy Considerations that Inform the Funding of Safety Surveillance in Low- and Middle-Income Countries: A Mixed Methods Study.
    Ogar CK; Quick J; Gilbert HN; Vreman RA; Mantel-Teeuwisse AK; Mugunga JC
    Drug Saf; 2023 Apr; 46(4):357-370. PubMed ID: 36811813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.